Study of Metabolic Content of Urine
Launched by UNIVERSITY OF WISCONSIN, MADISON · Dec 2, 2022
Trial Information
Current as of February 05, 2025
Completed
Keywords
ClinConnect Summary
The purpose of this research study is to analyze urine samples using Mass Spectrometry to identify metabolites that have the potential to be used for medical diagnosis. This data, along with data from wearable devices, will be combined and analyzed to correlate what an individual does on a daily basis with how their body metabolizes their choices. This type of data may provide insights into the origins and progression of diseases in a short time span.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Must be 18 years or older
- • Be able to provide informed consent
- • Stated willingness to comply with all study procedures and have availability for the duration of the study
- Exclusion Criteria:
- • Presence of a condition(s) or diagnosis, either physical or psychological, that limits the ability to urinate in the collection apparatus
- • Individuals who do not consistently get at least 6 hours of sleep per night
- • Individuals who have a sleep disorder diagnosis.
- • Individuals who live in the state of New York
Trial Officials
Joshua Coon, PhD
Principal Investigator
University of Wisconsin, Madison
About University Of Wisconsin, Madison
The University of Wisconsin-Madison is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive resources, including cutting-edge facilities and a diverse pool of expert researchers, to conduct rigorous studies that address critical health challenges. The institution's focus on translating research findings into practical applications fosters the development of new treatments and interventions, ultimately contributing to improved patient outcomes and public health initiatives. As a sponsor of clinical trials, the University of Wisconsin-Madison is dedicated to upholding the highest ethical standards and ensuring participant safety throughout the research process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madison, Wisconsin, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials